Cardiorenal syndrome;Síndrome cardiorrenal

Nefrologia

Volumn 28, Issue SUPPL. 3, 2008, Pages 29-32

  Pérez, J Portolés ^a   Bou, X Cuevas ^b  

^a HOSPITAL UNIVERSITARIO FUNDACIÓN ALCORCÓN   (Spain)

^b HOSPITAL DE TERRASSA   (Spain)

Author keywords

Anemia; Cardiorenal syndrome; Chronic kidney disease

Indexed keywords

EID: 51349149803     PISSN: 02116995     EISSN: None     Source Type: Journal    
DOI: None     Document Type: Article

References (22)

1. Go AS, Chertow GM, Fan D, McCulloch CE, Hsu Y. Chronic hidney disease and the risk of death, cardiovascular events and hospitalization. N Eng J Med 2004; 351: 1296-1305.
2. Amenábar JJ, García López F, Robles NR y cols. Informe de Diálisis y Trasplante de la Sociedad Española de Nefrología y Registros Autonómicos, año 2000. Nefrología 2002; 22: 310-317.
3. USRDS; the united states renal data system. USRDS 2003 Annual Data Report. Am J Kidney Dis 2003; 42 (S5): 1-230.
4. Keit DS, Nichols GA, Gullion CM, Brown JB, Smith DH. Longitudinal follow-up and outcomes among a population with chronic kidney disease in a large managed care organization Achv Inter Med 2004; 164: 659-663.
5. Górriz JL, Castelao AM, De Álvaro F, Portolés J, Luño J, Navarro J, Cases A. One year mortality and risk factors management in diabetic vs non-diabetic patients with CKD stages 3-4. Merena Study. J Am Soc Nephrol 2006; 17 (Supl.).
6. Kidney Disease Outcome Quality Initiative. K/DOQI clinical practice guidelinesfor chronic kidney disease; evaluation, classification, and stratification. Am J Kidney Dis 2002; 39 (Supl.): S1-S246.
7. Ljungman S, Kjekshus J, Swedberg K. Renal function in severe congestive heart failure during treatment with enalapril (the Cooperative North Scandinavian Enalapril Survival Study Trial). Am J Cardiol 1992; 70: 479-487.
8. The SOLVD Investigators. Effect of enalapril on survival in patients with reduced left ventricular ejection fractions and congestive heart failure. N Engl J Med 1992; 325: 293-302.
9. Chobanian AV, Bakris GL, Black HR y cols. The seventh report of the joint national committee on prevention, detection, evaluation, and treatment of high blood pressure: the JNC 7 report. JAMA 2003; 289: 2560-2573.
10. Go AS, Loa JC. Epidemiology of non-dialysis-requiring chronic kidney diseaseand cardiovascular disease. Current Curr Opin Nephrol Hypertens 2006; 15: 296-302.
11. Amann K, Wanner C, Ritz E. Cross-talk between the kidney and te cardiovascular sysem. J Am Soc Nephrol 2006; 17: 2112-2119.
12. Bongartz LG, Cramer MJ, Doevandans PA, Joles JA, Braam B. The severe cardiorenal syndrome: «Guyton revisited». European Heart Journal 2005; 26: 11-17.
13. Gottlieb SS, Abraham W, Butler J, Forman DE, Loh E, Massie BM, O'-Connor CM, Rich MW, Stevenson LW, Young J, Krumholz HM. The prognostic importance of different definitions of worsening renal function in congestive heart failure. J Card Fail 2002; 8: 136-14.
14. Shlipak MG. Pharmacotherapy for heart failure in patients with renal insufficiency. Ann Intern Med 2003; 138: 917-923.
15. Marín R, Goicoechea M, Gorostidi M. GUIAS SEN: Riñón y enfermedad cardiovascular. Nefrologia 2004; 24: S6.
16. Pfeffer MA, Swedberg K, Granger CB, Held P, McMurray JJV, Michelson EL y cols., for the CHARM investigators and committees. Effects of candesartan on mortality and morbidity in patients with chronic heart failure: the CHARM-Overall programme. Lancet 2003; 362: 759-66.
17. Bakris GL, Weir MR. Angiotensin-Converting enzyme inhibitor-associated elevations in serum creatinine. Arch Intern Med 2000; 160: 685-693.
18. Marik PE. Low-dose dopamine: a systematic review. Intens Care Med 2002; 28: 877-883.
19. Shlipak M G, Massie BM. The clinical challenge of cardiorenal syndrome. Circulation 2004; 110: 1514-1517.
20. Constanzo MR, Guglin ME, Salzberg MT, Jessup ML y cols. Ultrafiltration versus intravenous diuretics for patients hospitalized for acute decompensated heart failure. J Am Coll Cardiol 2007; 49: 675-83.
21. Silverberg DS, Wexler D, Blum M, Tchebiner JZ y cols. The effect of correction of anaemia in diabetics and non-diabetics with severe resistant congestive heart failure and chronic renal failure by subcutaneous erythropoietin and intravenous iron. Nephrol Dial Transplant 2003; 18: 141-146.
22. Drüeke TB, Locatelli F, Clyne N y cols. Normalization of hemoglobin level in patients with chronic kidney disease and anemia. N Engl J Med 2006; 355: 2071-84.